ACCENTRIX Trademark

Trademark Overview

On Thursday, April 17, 2003, a trademark application was filed for ACCENTRIX with the United States Patent and Trademark Office. The USPTO has given the ACCENTRIX trademark a serial number of 78238685. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Saturday, November 3, 2007. This trademark is owned by GENENTECH, INC.. The ACCENTRIX trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS OTHER THAN VACCINES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISORDERS, ONCOLOGICAL DISEASES AND DISORDERS, IMMUNE DISEASES AND DISORDERS, ANGIOGENESIS DISEASES AND DISORDERS, OCULAR DISEASES AND DISORDERS, OR INFLAMMATORY DISEASES AND DISORDERS

General Information

Serial Number78238685
Word MarkACCENTRIX
Filing DateThursday, April 17, 2003
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSaturday, November 3, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 9, 2003

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS OTHER THAN VACCINES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISORDERS, ONCOLOGICAL DISEASES AND DISORDERS, IMMUNE DISEASES AND DISORDERS, ANGIOGENESIS DISEASES AND DISORDERS, OCULAR DISEASES AND DISORDERS, OR INFLAMMATORY DISEASES AND DISORDERS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 24, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENENTECH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990
Party NameGENENTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990

Trademark Events

Event DateEvent Description
Wednesday, December 19, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, December 19, 2007ABANDONMENT - NO USE STATEMENT FILED
Monday, April 30, 2007EXTENSION 5 GRANTED
Monday, April 30, 2007EXTENSION 5 FILED
Monday, April 30, 2007TEAS EXTENSION RECEIVED
Tuesday, October 31, 2006EXTENSION 4 GRANTED
Tuesday, October 31, 2006EXTENSION 4 FILED
Tuesday, October 31, 2006TEAS EXTENSION RECEIVED
Tuesday, September 19, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2006EXTENSION 3 GRANTED
Wednesday, April 26, 2006EXTENSION 3 FILED
Wednesday, April 26, 2006TEAS EXTENSION RECEIVED
Friday, October 7, 2005EXTENSION 2 GRANTED
Friday, October 7, 2005EXTENSION 2 FILED
Friday, October 7, 2005TEAS EXTENSION RECEIVED
Friday, April 8, 2005EXTENSION 1 GRANTED
Friday, April 8, 2005EXTENSION 1 FILED
Friday, April 8, 2005TEAS EXTENSION RECEIVED
Friday, February 18, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 30, 2004FAX RECEIVED
Tuesday, November 2, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 8, 2004CASE FILE IN TICRS
Wednesday, August 18, 2004EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, July 15, 2004PAPER RECEIVED
Monday, July 5, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 6, 2004EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, December 15, 2003PAPER RECEIVED
Tuesday, December 9, 2003PUBLISHED FOR OPPOSITION
Tuesday, November 18, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 19, 2003NOTICE OF PUBLICATION
Monday, September 22, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 22, 2003ASSIGNED TO EXAMINER

Related Keywords

accentrix diseases disorders immune oncological angiogenesis inflammatory ocular cardiovascular other preparations